BioSpace News Archive

Bicara Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference.

Taysha Gene Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference.

Eikon is employing super-resolution microscopy and advanced engineering to invent novel medicines that improve and extend life.

Anebulo Pharmaceuticals, Inc. announced today that it has appointed Scott L. Anderson as Head of Investor Relations and Public Relations, effective immediately.

JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its Cognilum System.

Singular Genomics Systems, Inc. announced the company is collaborating with the Broad Institute of MIT and Harvard to connect the Singular Genomics G4 sequencer to Terra, a data platform co-developed by the Broad Institute, Microsoft and Verily that connects researchers to each other and to the datasets and tools they need to achieve scientific breakthroughs.

2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach.

Virtue Diagnostics, an innovative IVD company, has just announced closing US$100 million in Series B funding. Virtue Diagnostics, founded in 2019, is focused on clinical tests for China and emerging markets.

Osmotica Pharmaceuticals plc announced that Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and other key speakers, will host a call to discuss recent UPNEEQ® trends, pending expansion into the medical Aesthetics market and other general business updates as follows.

Praveen Tyle, Ph.D., Invectys Inc. President and CEO will provide an outlook for the business and its pipeline of treatments for cancer diseases and present an overview of all of Invectys’ projects to date on January 10th.